M Krmer: nothing to disclose, KG Haeusler: reports speakers honoraria, consulting fees, lecture honoraria and/or study grants from Abbott, Alexion, Amarin, AstraZeneca, Bayer Healthcare, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Medtronic, Novartis, Pfizer, Portola, Premier Research, Sanofi, SUN Pharma, and W.L
We encourage our community to take control of their health by seeking guidance from professionals who understand their unique needs
Racemization The conversion of an amino acid from its natural L-form to the D-form
Lamellar Architecture Tuning: Customizing the vesicle structure from Multi-Lamellar Vesicles (MLV) for sustained, depot-like release to Small Uni-Lamellar Vesicles (SUV) for rapid, deep-tissue permeation
It isnt FDA-approved, and it is still in the process of being evaluated in larger clinical trials
In experimental wound healing models, TB-500 treatment increases capillary density by 40-50% while improving functional blood flow restoration, demonstrating translation of cellular angiogenic activity into meaningful tissue-level perfusion benefits
